Medical and Pharmaceutical

Altas Biotechnologies Inc. donated nearly $300,000 to U of A for research over the next 2 years

Ireland's trial Medical Cannabis Access Program will offer patients Aurora CBD oil

Can cannabis ... is a new series where Mugglehead journalists investigate controversial claims about the uses of weed, in an effort to inform our readers and move the conversation forward.

The extract-focused company posted a 17 per cent drop in gross margin quarter-over-quarter (updated)

The study showed inhaling cannabis reduced migraine severity by 49.6 per cent

It's a different kind of flower power, but boomers are still enjoying its mellowing effects

A bong rip a day keeps frequent opioid use at bay for people self-medicating their chronic pain, according to the latest research from the BC Centre on Substance Use

Canada's earliest dispensaries and their patients should be exempt from the Cannabis Act, they say

An 'unusual' raid was carried out Thursday by provincial and local law enforcement

Missed objectives and a flop in sales dropped the company's stock to a two-year low

The medicines, made by GW Pharmaceuticals, are prescribed to treat severe childhood-onset epilepsy and spasticity caused by multiple sclerosis

The vertically integrated medicinal cannabis company's inaugural outdoor harvest yielded 10,300 kilograms of dried cannabis flower and cost just 10 cents per gram to produce

First-of-its-kind research points to cannabis as a treatment for PTSD symptoms

Tilray shares jumped after announcing it successfully imported medical cannabis into the U.S. in support of a new clinical trial on its use for treating breast cancer drug side effects

The marijuana titan expands its international presence with operations in a total of 12 countries by adding the two European nations.

Neptune Wellness Solutions Cannabis Business president Michel Timperio tells Mugglehead how the company moved from krill oil to the eighth highest ranked stock on the TSX30.

“Weediatrics: A Covert Medical Mission” shows how American parents who need medical cannabis for their sick or disabled children are forced to break federal laws.

The study, published in the Journal of Neuroscience, shows for the first time how CBD cancels out the negative side-effects of THC in rats such as paranoia, anxiety and addictive behaviours.

Michigan-based Pure Green claims its CBD-infused 'Parachute Pill' offers cannabis users a way to come down from a THC high in just five minutes.

America's most valuable pot firm is the first to sell dried flower products in New York, a move one analyst expects will help expand the state's patient base to 400,000 from today's 107,000.

U.S. Epidiolex sales have surged on strong patient uptake and now the CBD-based epilepsy drug could be sold in 31 European countries after EU authorities gave GW the green light.

At nearly the exact time Canopy announced its CEO hiring plans, Linton revealed he's joining two U.S. cannabis companies and one Toronto based medical psychedelic company.

Mugglehead talks to University of British Columbia's M-J Milloy who is studying how cannabis might help with opioid addiction while big pharma is being sued for millions.

The company behind a blockchain-based seed to sale tracking technology is bolstering its status by adding heavyweight auditing firm Deloitte and pot producer Aphria.

Mugglehead speaks with MediPharm president Keith Strachan about how the cannabis extraction pioneer is gearing up for the launch of Cannabis 2.0 products in Canada.

A recent American Society of Anesthesiologists survey shows an escalating interest in marijuana for managing pain among U.S. adults, but the ASA warns more research is needed.

The former New England Patriots tight end will promote CBD products for Rhode Island-based Abacus Health while calling on the NFL to allow athletes to use the touted wellness extract.

Analysts have been bullish on the U.K. drugmaker raising estimates and price targets after its second-quarter sales easily surpassed expectations.

The initiative will allow Oregon customers to purchase a Curaleaf custom-designed pre-roll product, with a portion of all proceeds benefiting the Veterans Cannabis Project.

Louisiana joins more than 30 U.S. states, and the first one in the Deep South, with a medical cannabis program that officially began on Aug. 6 after a four-year regulatory hurdle.

Tiny Luxembourg could have a big effect on cannabis legalization in the European Union and open up the market for pot once the country goes recreational in two years.

A Tel Aviv-based team at Weedley is launching several clinical studies to test if CBD is an effective and safe way to treat pain in dogs and horses.

The Edmonton-based pot producer will supply 400 kilograms of medical cannabis to Italy under the contract, but securing the bid at $2.54 per gram may actually hurt Aurora's bottom line.

Researchers found the number of U.S. high school students who said they used pot at least once a month jumped from 0.6 per cent in 1991 to 6.3 per cent in 2017.

One-in-four medical cannabis users said supply issues have been preventing them from getting the medicine they need, according to a survey commissioned by Canadian Pharmacists Association and two other groups.

Gov. Phil Murphy signed the Jake Honig Compassionate Use Medical Cannabis Act on Tuesday, to make cannabis more accessible for patients battling disease and needing pain relief.

Ireland's Health Minister signed legislation last week which will allow citizens to gain limited access to medical cannabis to treat multiple sclerosis, chemotherapy-related illness and epilepsy.

It took eight years and $83 million dollars for Tel Aviv-based Syqe Medical to develop the new product that will allow medical marijuana patients to take accurate doses.

Toronto-based CannaHorse announced Wednesday it launched the world's first-ever legal cannabis brand dedicated to horse health.

Next fall, the University of Maryland School of Pharmacy will offer a two-year master's program designed for health care practitioners, scientists, regulators, and industry professionals.